2 unchanged sentences
Filed/Furnished
−Removed: Letter Agreement I to the Collaboration Agreement and the Development Services and Clinical Supply Agreement, dated March 30, 2023, by and between the Registrant and Catalent Maryland, Inc.
−Removed: Letter Agreement II to the Collaboration Agreement and the Development Services and Clinical Supply Agreement, dated March 30, 2023, by and between the Registrant and Catalent Maryland, Inc.
+Added: Restated Certificate of Incorporation, dated May 30, 2023
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
16 unchanged sentences
as Inline XBRL and contained in Exhibit 101)
−Removed: Registrant has omitted portions of the exhibit as permitted under Item 601(b)(10) of Regulations S-K.
This certification is deemed not filed for purposes of section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
1 unchanged sentence
PASSAGE BIO, INC.
+Added: August 7, 2023
/s/ William Chou
President and Chief Executive Officer
−Removed: /s/ Simona King
−Removed: Chief Financial Officer
+Added: August 7, 2023
+Added: /s/ Kathleen Borthwick
+Added: Kathleen Borthwick
+Added: Interim Chief Financial Officer
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.